SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in combination with one of the largest clinical proteomic databases in the world, SomaLogic aims to revolutionize precision medicine to help address unmet medical needs. For more information, visit www.somalogic.com and follow @somalogic on Twitter.